In-Body Electromagnetic Sensor Combined with AI-Enhanced Electrocardiography for Pacemaker Working Status Telemonitoring

This paper describes the design and implementation of an in-body electromagnetic sensor for patients with implanted pacemakers. The sensor can either be mounted on myocardial tissue and monitor the electrocardiography (ECG) with contact electrodes or implanted under the skin and monitor the ECG with coaxial leads. A 16-bit high-resolution analog front-end (AFE) and an energy-efficient 32-bit CPU are used for instantaneous ECG recording. Wireless data transmission between the sensor and clinician’s computer is achieved by an embedded low-power Bluetooth transmitter. In order to automatically recognize the working status of the pacemaker and alarm the episodes of arrhythmias caused by pacemaker malfunctions, pacing mode classification and fault diagnosis on the recorded ECG were achieved based on an AI algorithm, i.e., a resource allocation network (RAN). A prototype of the sensor was implemented on a human torso, and the in vitro test results prove that the sensor can work properly for the 1-4-meter transmission range.

Comparative In vitro Metabolism of Enflicoxib in Dogs, Rats, and Humans: Main Metabolites and Proposed Metabolic Pathways

Background: Enflicoxib is a non-steroidal anti-inflammatory drug of the coxib family characterized by a long-lasting pharmacological activity that has been attributed to its active metabolite E-6132. Objective: The aim of this work was to explore enflicoxib biotransformation in vitro in humans, rats and dogs, and to determine its metabolic pathways. Method: Different in vitro test systems were used, including hepatocytes and liver and non-hepatic microsomes. The samples were incubated with enflicoxib and/or any of its metabolites at 37°C for different times depending on the test system. The analyses were performed by liquid chromatography coupled with either radioactivity detection or high-resolution mass spectrometry. Results: Enflicoxib was efficiently metabolized by cytochrome P-450 into three main phase I metabolites: M8, E-6132, and M7. The non-active hydroxy-pyrazoline metabolite M8 accounted for most of the fraction metabolized in all the three species. The active pyrazol metabolite E-6132 showed a slow formation rate, especially in dogs, whereas metabolite M7 was a secondary metabolite formed by oxidation of M8. In hepatocytes, diverse phase II metabolite conjugates were formed, including enflicoxib glucuronide, M8 glucuronide, E-6132 glucuronide, M7 glucuronide, and M7 sulfate. Metabolite E-6132 was most probably eliminated by a unique glucuronidation reaction at a very low rate. Conclusion: The phase I metabolism of enflicoxib was qualitatively very similar among rats, humans and dogs. The low formation and glucuronidation rates of the active enflicoxib metabolite E-6132 in dogs are postulated as key factors underlying the mechanism of its long-lasting pharmacokinetics and enflicoxib's overall sustained efficacy.

Safety and Efficacy of Prosopis juliflora Leaf Extract as a Potential Treatment against Visceral Leishmaniasis in Balb/c Mice

Background: Visceral Leishmaniasis caused by Leishmania donovani is a major health problem in the tropics and sub-tropic regions where it is endemic. We aimed in testing the leishmanicidal activity and toxicity of Prosopis juliflora leaf extract in BALB/c mice and in vitro test systems respectively. Methods: In the year 2017 until 2019, BALB/c mice of mixed sexes aged between 6 and 8 weeks in groups of 8 were used. Group I treated with 100 mg/kg of P. juliflora extract, Group II -1 mg/kg of Sodium stibogluconate (SSG) and Group III treated with normal saline. All mice were anaesthized and sacrificed to obtain blood, spleen samples for antibody measurements, and determination of parasite loads. Results: There was significant inhibitory effect (P<0.05) exhibited by P. juliflora leaf extract on promastigote growth during the in vitro test whereby up to 98% parasites were killed at the highest concentrations of 100 µg/Ml of the extract as compared to SSG, which showed less inhibitory effect on promastigotes. P. juliflora exhibited a higher splenic antiamastigote effect after 21 days of administration as compared to SSG. P. juliflora methanolic leaf extract induced a higher total IgG level as compared to the reference drug which could be attributed to higher titer in IgG2a subtype in mice treated with the extract, which was not induced in mice, treated with SSG. Conclusion: P. juliflora exhibited higher inhibitory effects against L. donovani promastigotes as well as amastigotes and induced significantly higher IgG antibody levels as compared to SSG (P<0.05). Furthermore, it was safer than SSG on Vero E6 cells.

Efficacy of some Egyptian native plant extracts against Haemonchus contortus in vitro and in experimentally infected sheep along with the associated haematological and biochemical alterations

Background Haemonchosis is a serious disease affecting ruminants’ productivity worldwide. Medicinal plants are deemed one of the most natural bio-products safely used as alternatives to the synthetic anthelmintics. In the present study, comparative efficacy of crude ethanolic extracts (CEEs) of Artemisia herba-alba (A. herba-alba), Balanites aegyptiaca (B. aegyptiaca) and Allium sativum (A. sativum) as alternative treatments was tested on Haemonchus contortus ( H. contortus). An in vitro test to evaluate the anthelmintic efficacy of various concentrations of extracts at 25, 30 and 50 mg/ml was accomplished on motility and viability of adult worms in comparison with albendazole, reference drug at 10 μg/ml at various time intervals. An in vivo test was carried out in lambs experimentally infected with H. contortus to detect anthelmintic activity of CEEs of A. herba-alba and B. aegyptiaca compared to albendazole. Fifteen parasite-free Baladi Egyptian lambs aged 4–8 months old were categorized into five groups, each of three lambs as follows: G1 was kept as uninfected untreated one, G2 was utilized as infected untreated group, G3 was given CEE of A. herba-alba, G4 was received CEE of B. aegyptiaca, and G 5 was treated with albendazole. Results The in vitro test revealed that CEE of B. aegyptiaca had the most significant anthelmintic activity on adult H. contortus followed by A. herba-alba, while A. sativum was of the lowest effect. The in vivo test showed that the CEE of B. aegyptiaca achieved an excellent faecal egg reduction (100%) at the 7th day post-treatment. The most efficient treatments that improved the haematological parameters and regained the level of serum total protein, albumin and A/G ratio, serum globulin, SGoT, SGPT, urea and creatinine to the almost normal levels were CEE of B. aegyptiaca, albendazole and CEE of A. herba-alba, respectively. Conclusions This study highlighted the marked anthelmintic potency of the CEEs of B. aegyptiaca and A. herba-alba on H. contortus and the superiority of CEE of B. aegyptiaca as a talented anti-parasitic medicinal plant for sheep.

Monocarbonyl Analogs of Curcumin Based on the Pseudopelletierine Scaffold: Synthesis and Anti-Inflammatory Activity

Curcumin (CUR) is a natural compound that exhibits anti-inflammatory, anti-bacterial, and other biological properties. However, its application as an effective drug is problematic due to its poor oral bioavailability, solubility in water, and poor absorption from the gastrointestinal tract. The aim of this work is to synthesize monocarbonyl analogs of CUR based on the 9-methyl-9-azabicyclo[3.2.1]nonan-3-one (pseudopelletierine, granatanone) scaffold to improve its bioavailability. Granatane is a homologue of tropane, whose structure is present in numerous naturally occurring alkaloids, e.g., l-cocaine and l-scopolamine. In this study, ten new pseudopelletierine-derived monocarbonyl analogs of CUR were successfully synthesized and characterized by spectral methods and X-ray crystallography. Additionally, in vitro test of the cytotoxicity and anti-inflammatory properties of the synthesized compounds were performed.

A compact in vitro test bench for cardiovascular flow analysis

A low-cost particle image velocimetry set-up that allows to investigate the fluid dynamics inside realistic coronary artery phantoms has been implemented. The proposed smart test bench for experimental characterization of arterial hemodynamics also in the presence of implanted devices represents a low-cost equipment that can be easily implemented in non-expert laboratories for research as well as educational applications.

Biocompatibility of Alginate -Graphene Oxide Film for Tissue Engineering Applications

The present paper indicates promising potential of Sodium Alginate) Alg)/Graphene oxide (Go) films in fields bone tissue engineering (TE). The Sodium Alginate (Alg)/Graphene oxide (Go) films, were fabricated via (solvent casting method). The interaction of Sodium Alginate (Alg) with Graphene oxide (Go) via hydrogen bonding was confirmed by FTIR analysis. The swelling degree of Sodium Alginate (Alg)/Graphene oxid (Go) films was also studied. Furthermore, the biocompatibility of Sodium Alginate (Alg)/Graphene oxide (Go) films disclosed its non-cytotoxic effect on the cell lines (MG-63) in-vitro test, the viability of cell lines on the films, and hence its appropriateness as potent biomaterial for tissue engineering.

Effect of Powder/Water Ratio Variation on Viscosity, Tear Strength and Detail Reproduction of Dental Alginate Impression Material (In Vitro and Clinical Study)

Background: Alginate impression is a common dental polymeric material, presented as powder to be mixed with water. Aim: 1. To analyze the effect of alginate powder/water ratio variation on viscosity, tear strength and detail reproduction by in vitro tests, and 2. To evaluate this variation’s effect on patients’ impressions. Materials and methods: Two commercial alginate products were mixed in different viscosities. Viscosity was measured by a viscometer. For the tear strength test, V-shaped specimens were used. For detail reproduction, a die with three scribed lines was used. Clinical dental impressions were examined by stereomicroscope. Results: The alginate specimens mixed with a higher powder/water ratio showed a higher viscosity and tear strength compared to those with a lower powder/water ratio. Both alginate mixtures reproduced two scribed lines in a detail reproduction test. On the other hand, no clear clinical difference was detected when examining dental impressions mixed with a different powder/water ratio. Conclusion: Although increasing the powder/water ratio of mixed alginate raised the resultant viscosity and tear strength by an in vitro test, clinically, no clear difference in tearing was detected. Detail reproduction was minimally affected by the variation in powder/water ratio.

Combination of Mussel Inspired Method and “Thiol-Michael” Click Reaction for Biocompatible Alginate-Modified Carbon Nanotubes

Carbon nanotubes (CNTs) have attracted great interest in biomedical fields. However, the potential toxicity and poor dispersion of CNTs have greatly limited its application. In this work, a mussel-inspired method combined with the “thiol-Michael” click reaction was used to modify the surface of CNT and improve its properties. Firstly, a CNT was treated with dopamine, and then alginate grafted with L-cysteine was anchored onto the surface of CNT via click reaction, which realized the long-time dispersion of CNT in water. Furthermore, the in vitro test also demonstrated that the alginate may improve the biocompatibility of CNT, and thus may broaden the application of CNT in the biomedical field.